Skip to main content

Day: June 15, 2022

RioCan Real Estate Investment Trust Announces June 2022 Distribution

TORONTO, June 15, 2022 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced a distribution of 8.5 cents per unit for the month of June. The distribution will be payable on July 8, 2022 to unitholders of record as at June 30, 2022. About RioCanRioCan is one of Canada’s largest real estate investment trusts. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians want to shop, live and work. As at March 31, 2022, our portfolio is comprised of 204 properties with an aggregate net leasable area of approximately 36.2 million square feet (at RioCan’s interest) including office, residential rental and 13 development properties. To learn more about us, please visit www.riocan.com.CONTACT:...

Continue reading

Peyto Exploration & Development Corp. Confirms Monthly Dividend for July 15, 2022

CALGARY, Alberta, June 15, 2022 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to June 2022 of $0.05 per common share is to be paid on July 15, 2022, for shareholders of record on June 30, 2022. The ex-dividend date for the June dividend is June 29, 2022. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the CEO and includes estimates of monthly capital expenditures and production. For further information please...

Continue reading

Melcor REIT announces June 2022 distribution of $0.04 per unit

EDMONTON, Alberta, June 15, 2022 (GLOBE NEWSWIRE) — Melcor Real Estate Investment Trust (TSX: MR.UN) today announced that the Trustees of the REIT have declared cash distributions of $0.04 per unit for the month of June 2022, unchanged from previous months. The June distributions will be payable as follows:Month Record Date Distribution Date Distribution AmountJune 2022 June 30, 2022 July 15, 2022 $0.04 per unitMelcor REIT results for the second quarter ended June 30, 2022 will be released on July 26, 2022 after market close. Management will host a conference call at 11:00 am ET (9:00 am MT) on Wednesday, July 27, 2022. Q2 Conference Call Toronto & Area: 1-416-915-3239Toll Free: 1-800-319-4610 Webcast & Replay The call will also be webcast (listen only) at https://www.gowebcasting.com/11855. A replay of the...

Continue reading

NextPlay Technologies Delays Filing of Annual Report on Form 10-K

SUNRISE, FL, June 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – NextPlay Technologies, Inc. (NASDAQ: NXTP), a digital business ecosystem for digital advertisers, consumers, video gamers and travelers, today announced that the filing of its Annual Report on Form 10-K for the fiscal year ended February 28, 2022 (the “Annual Report”) will not occur prior to the extended June 15, 2022 deadline.  On May 31, 2022, the Company filed a Notification of Late Filing on Form 12b-25 (the “12b-25”), indicating that the filing of its Annual Report will be delayed, due in large part to accounting and auditing implications resulting from material acquisitions made by the Company during the fiscal year ended February 28, 2022. Although the Company has dedicated significant resources to the completion of its audited consolidated financial statements...

Continue reading

Actelis Networks to Report Fiscal First Quarter 2022 Financial Results on Wednesday, June 22, 2022 at 4:30 p.m. ET

FREMONT, Calif., June 15, 2022 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, will hold a conference call on Wednesday, June 22, 2022 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fiscal first quarter ended March 31, 2022. Company CEO Tuvia Barlev and CFO Yoav Efron will host the call. Date: Wednesday, June 22, 2022Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)U.S. dial-in (toll-free): 844-830-1956International dial-in: +12133202553Conference ID: 9356273 Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference...

Continue reading

Roivant Sciences to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022 on Tuesday, June 28, 2022

Investor call and webcast scheduled for Tuesday, June 28 at 8:00 a.m. EDTBASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 15, 2022 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV), a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. EDT on Tuesday, June 28, 2022 to report its financial results for the fourth quarter and fiscal year ended March 31, 2022 and provide a corporate update. To access the live conference call, please dial +1-844-224-1923 (domestic) or +1-214-989-7105 (international) and use conference ID 1036178. A webcast of the call will also be available under “Events & Presentations” in the Investors section of the Roivant website at https://investor.roivant.com/news-events/events....

Continue reading

Atico Announces Approval of Amended and Restated Stock Option Plan by Shareholders

VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) — Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) announces following the Company’s annual general meeting of shareholders, held on June 14, 2022, that shareholders of the Company approved the adoption of the Company’s amended and restated stock option plan (the “Amended and Restated Option Plan”). The Company’s stock option plan was originally adopted by the board of directors on June 2, 2011, and previously amended on May 27, 2015. The total number of common shares of the Company (the “Common Shares”) reserved and available for grant and issuance under the Amended and Restated Option Plan shall be a rolling number equal to 10% of the total issued and outstanding Common Shares from time to time. As further discussed in the Company’s management...

Continue reading

Yamana Gold Releases 2021 Sustainability Report

TORONTO, June 15, 2022 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX:YRI; NYSE:AUY; LSE:AUY) (“Yamana” or “the Company”) has published its 2021 Sustainability Report. This provides a comprehensive overview of Yamana’s environmental, social, and governance (“ESG”) performance, alongside the approach and philosophy that underpins the Company’s commitment to ESG excellence. Highlights:The adoption of a Responsibility Policy and eight Statements of Commitment describing the Company’s statements of principle and intent, covering all functional aspects of Health, Safety and Sustainable Development. The continuing work to limit the impact of COVID-19 on the Company’s workforce, host communities and business, including the high vaccination rates that have been achieved in all operating jurisdictions. The commitment to reduce greenhouse gas...

Continue reading

Algernon Pharmaceuticals Announces Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) is pleased to announce that it is undertaking a marketed public offering of units of the Company (the “Units” or the “Offered Securities”) with Research Capital Corporation as the sole agent and sole bookrunner (the “Agent”), in each of the provinces of Canada (other than Quebec) (the “Offering”). The size of the Offering and price of the Units will be determined in the context of the market. Each Unit will consist of one Class A common share of the Company (a “Common Share“) and one Common Share purchase warrant of the Company (a “Warrant“). Each Warrant entitles...

Continue reading

Clearmind Medicine Appoints New Chief Financial Officer

VANCOUVER, June 15, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the appointment of Mr. Alan Rootenberg as Chief Financial Officer, effective June 14, 2022. The Company thanks Mr. Oded Gilboa for his contribution to the Company, as CFO. Mr. Gilboa has also left his role as a director of the company.  About Clearmind Inc. (CSE: CMND), (OTC: CMNDF), (FSE: CWY0) Clearmind is a biotech company focused on the discovery and development of safe and novel psychedelic-derived therapeutics to treat alcohol use disorder and other pressing health challenges. The Israeli Canadian company holds several...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.